Pharmacyte Biotech Inc (PMCB) Annual Balance Sheets

Annual · GAAP · USD millions
Access PMCB quarterly Balance Sheets →
A period-by-period view of the balance sheet from Pharmacyte Biotech Inc to Apr 30 2022 helps clarify how Apr 30 2026's financial structure has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Apr 30 2026)
(Apr 30 2025) (Apr 30 2024) (Apr 30 2023) (Apr 30 2022)
Assets
Cash & cash equivalent18.60
Marketable Securities, Current SH0.25
Cash & Short-term Investments18.00
Other Receivables0.24
Other Current Assets18.23
Prepaid Expense And Other Assets Current0.10
Total Current Assets37.42
Intangible Assets0.00
Long-term investments0.00
Tax Assets, Noncurrent19.37
Other Assets, Noncurrent0.00
Warrant Asset Current2.92
Convertible Note Receivable Current3.70
Warrant Asset Femasys3.06
Total Assets46.75
Liabilities
Accounts Payable, Current AC0.27
Accrued Liabilities, Current AC0.52
Financial Instruments2.00
Other Liabilities, Current0.00
Total Current Liabilities0.83
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.88
Other liabilities, Noncurrent10.07
Warrant Liabilities Noncurrent0.34
Total Liabilities11.77
Stockholders' Equity
Treasury Stock Common Value-44.61
Common Stock Value0.00
Additional Paid In Capital Common Stock182.72
Retained Earnings / Accumulated Deficit-104.39
Accumulated Other Comprehensive Income-0.02
Other Equity-0.02
Common Stockholder's Equity33.29
Non-controlling interests & other0.00
Total Stockholder's Equity33.29
Liabilities & Stockholder's Equity46.75
4 historic quarters locked

Sign in to unlock the full Pharmacyte Biotech Inc balance sheet history.

About Pharmacyte Biotech Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-005836

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License